Pharma in review: trending stories 8/30/19

Aug 30, 2019

number1

Boehringer pharma head to step down

The drugmaker announced changes in its board of managing directors, beginning with Allan Hillgrove.


number2FDA widens drug recall probe beyond heart meds
The FDA is expanding its investigation related into impurities found in a class of blood pressure medications.

number3Blockbuster-bound Lilly drug wins another FDA nod

 Eli Lilly’s Taltz has been given the go-ahead for a new indication.

 

number4

Oklahoma judge rules against J&J in landmark trial

A judge has ordered Johnson & Johnson to pay $572 million in damages for its role in the opioid epidemic.

 

number5

FDA fast tracks AstraZeneca diabetes drug

Farxig, has been given fast track status as a method to prevent heart and kidney failure in patients with chronic kidney disease.

 

Don't miss your Daily Dose. Get news like this delivered right to your inbox.